MG
GH icon

Mather Group’s Guardant Health GH Stock Holding History

Mather Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$62 – 1035
2025
Q3 		$62 Buy
+1
New +$54 ﹤0.01% 1692
2025
Q2 		– Sell
-1
Closed -$43 – 1043
2025
Q1 		$43 Hold
1
– – ﹤0.01% 1775
2024
Q4 		$31 Hold
1
– – ﹤0.01% 1738
2024
Q3 		$23 Buy
+1
New +$28 ﹤0.01% 1692

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mather Group's GH Position: Q4 2025 in Review

Mather Group sold out of Guardant Health (GH) in Q4 2025, closing a stake of 1 share — an estimated $62 sold.

Mather Group first reported a position in GH in Q3 2024 and held it in 4 quarters. The position peaked at $62 in Q3 2025. 497 funds tracked by Wall St. Rank hold GH as of Q4 2025.

  • Mather Group reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
  • Mather Group sold 1 Guardant Health share in Q4 2025, an estimated $62.
  • Mather Group first reported a position in Guardant Health in Q3 2024 and held it in 4 quarters.
  • Mather Group's Guardant Health position peaked at $62 in Q3 2025.
  • 497 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Mather Group's 13F filing for Q4 2025, filed 13 Jan 2026.